Feasibility of Egg-Based Diet Interventions and Assessing Perinatal Mental Health
Primary Purpose
Depression, Anxiety, Stress
Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Whole Liquid Egg
Plant-based Egg Substitute
Sponsored by
About this trial
This is an interventional prevention trial for Depression
Eligibility Criteria
Inclusion Criteria: 18 to 26 weeks pregnant have access to internet and an electronic device (phone, tablet, or computer) willing to consume eggs Exclusion Criteria: score 11 or higher on the Edinburgh Postnatal Depression Scale under 19 years of age non-English speaking pregnant with multiples consume a vegan diet self-reported use of alcohol or drugs during pregnancy have diagnosed egg allergy have physical, cognitive, or logistical limitations to being able to follow the study protocol do not plan to breastfeed
Sites / Locations
- University of IdahoRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Whole Liquid Egg
Plant-Based Egg Substitute
Arm Description
Whole Liquid Eggs
Plant-Based Egg Substitute
Outcomes
Primary Outcome Measures
Serum Choline
Blood will be collected and analyzed via liquid chromatography-stable isotope dilution-multiple reaction monitoring mass spectrometry
Serum Choline
Blood will be collected and analyzed via liquid chromatography-stable isotope dilution-multiple reaction monitoring mass spectrometry
Adherence
Daily photo and written diet logs will be analyzed to determine dietary intake of the intervention foods
Feasibility/Compliance
Percent of subjects who complete all study surveys will be calculated to report feasibility of collecting repeated measures of dietary intake and mental health surveys.
Secondary Outcome Measures
Breastmilk Choline
Breastmilk will be collected and analyzed via liquid chromatography-stable isotope dilution-multiple reaction monitoring mass spectrometry
Depression
Maternal depressive symptoms will be measured via the Edinburgh Postnatal Depression Scale. Maximum score is 30. Higher scores indicate increased symptoms of depression.
Depression
Maternal depressive symptoms will be measured via the Edinburgh Postnatal Depression Scale. Maximum score is 30. Higher scores indicate increased symptoms of depression.
Anxiety
Maternal anxiety will be measured with the 31-item perinatal anxiety screening scale. Maximum score is 93. Higher scores indicate higher symptoms of anxiety.
Anxiety
Maternal anxiety will be measured with the 31-item perinatal anxiety screening scale. Maximum score is 93. Higher scores indicate higher symptoms of anxiety.
Stress
Maternal perceived stress levels will be characterized via the Perceived Stress Scale. The maximum score is 56. Higher scores indicate higher levels of perceived stress.
Stress
Maternal perceived stress levels will be characterized via the Perceived Stress Scale. The maximum score is 56. Higher scores indicate higher levels of perceived stress.
Perceived social support
Subjects will complete the Multidimensional Scale of Perceived Social Support. The maximum score is 7. Higher scores indicate higher levels of perceived support.
Perceived social support
Subjects will complete the Multidimensional Scale of Perceived Social Support. The maximum score is 7. Higher scores indicate higher levels of perceived support.
Serum cortisol
Blood draw will be analyzed for concentration of serum cortisol using an enzyme-linked immunosorbent assay
Serum cortisol
Blood draw will be analyzed for concentration of serum cortisol using an enzyme-linked immunosorbent assay
Full Information
NCT ID
NCT05619445
First Posted
October 24, 2022
Last Updated
June 28, 2023
Sponsor
University of Idaho
Collaborators
University of Nevada, Las Vegas, University of New Mexico
1. Study Identification
Unique Protocol Identification Number
NCT05619445
Brief Title
Feasibility of Egg-Based Diet Interventions and Assessing Perinatal Mental Health
Official Title
Feasibility of Egg-Based Diet Interventions and Assessing Perinatal Mental Health
Study Type
Interventional
2. Study Status
Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 9, 2023 (Actual)
Primary Completion Date
October 30, 2023 (Anticipated)
Study Completion Date
December 30, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Idaho
Collaborators
University of Nevada, Las Vegas, University of New Mexico
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The goals of this study are to assess the feasibility and acceptability of a dietary intervention to increase choline intake through whole foods (eggs) in pregnant and lactating women for mental health benefits. We will achieve these goals through the following specific aims:
To determine the effects of including eggs as a source of choline in the diets of pregnant and lactating women on biomarkers, we will measure concentrations of choline and choline metabolites in maternal serum and breastmilk at 24-26 weeks gestation and 4-6 weeks postpartum.
To evaluate adherence to a food-based dietary choline intervention in pregnant and lactating women, we will track intake via daily photo and written food logs.
To assess the feasibility of collecting repeated measures of dietary intake and maternal depression, anxiety, and stress in the perinatal period, we will track completion rates for project surveys.
The data from this study will inform the design and sample size calculations for a longitudinal cohort study that will assess neurological outcomes for both mother and child and follow the offspring over time to reassess mental health and cognitive development in preschool-aged children.
Choline is an underconsumed nutrient of concern for public health, specifically during pregnancy and lactation. There is limited data on biomarker or health outcomes related to perinatal choline intake. Determining relationships between perinatal choline intake and maternal mental health has the potential to impact public health by ultimately informing development of nutrition education materials in the clinical setting focused on encouraging maternal perinatal choline intake through whole foods such as eggs.
Detailed Description
Subjects will be recruited from community sites, such as health clinics and recreation centers. Practitioners and recreation center directors will collaborate by sharing a recruitment flyer with patients and clients. Doctor's clearance is not required for participation, but potential subjects may discuss the study with their physician. Potential subjects will complete an online screening form. Eligible subjects (n=30) will be 18 to 26 weeks pregnant (at study start, mid-July), have access to internet and an electronic devise (phone, tablet, or computer), and be willing to consume eggs and consent to study participation. Eligible subjects will be sent an electronic informed consent and be contacted by study personnel. Study personnel will review the consent either in person, via phone, or via zoom. Those eligible for the study will be randomly assigned to the dietary intervention groups: whole liquid eggs (n=15) or plant-based liquid egg substitute (JUST Egg) (n=15).
After consenting, subjects will complete baseline surveys. Baseline survey data collected will include an online demographic and health history questionnaire, food frequency questionnaire, 24-hour dietary recall, and self-report surveys to assess depressive symptoms, anxiety, perceived stress, and perceived social support. Subjects will complete all assessments online (via Qualtrics) using their own electronic devices, including phone, tablet, or computer, from the comfort of their own home.
Subjects will then be scheduled to come to the Ramsay Research unit (RRU) for fasted blood draw (overnight fast, 8 hours). Subjects will be scheduled between 7:30am and 11am. The RRU is not a CLIA-certified laboratory. It is an approved research laboratory. Blood will be processed at the RRU and sent to the Chen lab on the UI Moscow campus for cortisol analysis and to the University of North Carolina Nutrition Research Institute for choline analysis. At this baseline visit, subjects will also receive the first 30 day supply of the assigned dietary intervention along with a simple recipe book to offer ideas for preparation in case subjects are not familiar with how to prepare liquid eggs and to reduce monotony and palate fatigue. Subjects will also receive a measuring cup and a diet log along with instructions for consuming the intervention food and reporting intake daily via photos and written log. Researchers will answer any questions. Subjects will receive baseline data collection compensation.
Subjects will pick up additional dietary intervention products at the Carmelita Spencer Foods laboratory every 30 days (total of 120 days). Alternatively, research personnel will deliver products to subjects' homes in the Moscow area.
Subjects will be asked to take a photo of each meal that incorporates their assigned dietary intervention food before and after eating. These photos will be sent to the study phone via text message and uploaded to the PI's secure university One Drive account.
Subjects will be asked to complete additional online 24-hour diet recalls at week 9-10 of the intervention (about week 35-36 gestation), and week 18-19 of the intervention (about 4-5 weeks postpartum).
At week 4-6 postpartum, subjects will complete a short survey online describing birth-related outcomes and experience and self-report surveys to assess depressive symptoms, anxiety, perceived stress, and perceived social support.
Also at 4-6 weeks postpartum, subjects will come to the Ramsay Research Unit for fasted blood draw (overnight fast, 8 hours) and to provide a sample of breastmilk. Subjects will be scheduled between 7:30am and 11am. Subjects will be asked to refrain from feeding their infant on one breast for the 2 hours prior to collection. An electronic breast pump will be provided and a lactation specialist will be available to assist in this collection. Subjects will be asked for a full expression from one breast. Blood will be processed as described above. Breastmilk will sent to the UNC Nutrition Research Institute for choline analysis.
This will complete the data collection and subjects will receive study completion compensation.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depression, Anxiety, Stress
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
30 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Whole Liquid Egg
Arm Type
Experimental
Arm Description
Whole Liquid Eggs
Arm Title
Plant-Based Egg Substitute
Arm Type
Experimental
Arm Description
Plant-Based Egg Substitute
Intervention Type
Other
Intervention Name(s)
Whole Liquid Egg
Intervention Description
Subjects will consume 2 fluid ounces of whole liquid eggs per day for 120 days.
Intervention Type
Other
Intervention Name(s)
Plant-based Egg Substitute
Intervention Description
Subjects will consume 2 fluid ounces of liquid plant-based egg substitute (JUST eggs) per day for 120 days.
Primary Outcome Measure Information:
Title
Serum Choline
Description
Blood will be collected and analyzed via liquid chromatography-stable isotope dilution-multiple reaction monitoring mass spectrometry
Time Frame
Baseline
Title
Serum Choline
Description
Blood will be collected and analyzed via liquid chromatography-stable isotope dilution-multiple reaction monitoring mass spectrometry
Time Frame
4-6 weeks postpartum
Title
Adherence
Description
Daily photo and written diet logs will be analyzed to determine dietary intake of the intervention foods
Time Frame
Daily through the dietary intervention (120 days)
Title
Feasibility/Compliance
Description
Percent of subjects who complete all study surveys will be calculated to report feasibility of collecting repeated measures of dietary intake and mental health surveys.
Time Frame
Through study completion, approximately 4 months
Secondary Outcome Measure Information:
Title
Breastmilk Choline
Description
Breastmilk will be collected and analyzed via liquid chromatography-stable isotope dilution-multiple reaction monitoring mass spectrometry
Time Frame
4-6 weeks postpartum
Title
Depression
Description
Maternal depressive symptoms will be measured via the Edinburgh Postnatal Depression Scale. Maximum score is 30. Higher scores indicate increased symptoms of depression.
Time Frame
Baseline
Title
Depression
Description
Maternal depressive symptoms will be measured via the Edinburgh Postnatal Depression Scale. Maximum score is 30. Higher scores indicate increased symptoms of depression.
Time Frame
4-6 weeks postpartum
Title
Anxiety
Description
Maternal anxiety will be measured with the 31-item perinatal anxiety screening scale. Maximum score is 93. Higher scores indicate higher symptoms of anxiety.
Time Frame
Baseline
Title
Anxiety
Description
Maternal anxiety will be measured with the 31-item perinatal anxiety screening scale. Maximum score is 93. Higher scores indicate higher symptoms of anxiety.
Time Frame
4-6 weeks postpartum
Title
Stress
Description
Maternal perceived stress levels will be characterized via the Perceived Stress Scale. The maximum score is 56. Higher scores indicate higher levels of perceived stress.
Time Frame
Baseline
Title
Stress
Description
Maternal perceived stress levels will be characterized via the Perceived Stress Scale. The maximum score is 56. Higher scores indicate higher levels of perceived stress.
Time Frame
4-6 weeks postpartum
Title
Perceived social support
Description
Subjects will complete the Multidimensional Scale of Perceived Social Support. The maximum score is 7. Higher scores indicate higher levels of perceived support.
Time Frame
Baseline
Title
Perceived social support
Description
Subjects will complete the Multidimensional Scale of Perceived Social Support. The maximum score is 7. Higher scores indicate higher levels of perceived support.
Time Frame
4-6 weeks postpartum
Title
Serum cortisol
Description
Blood draw will be analyzed for concentration of serum cortisol using an enzyme-linked immunosorbent assay
Time Frame
Baseline
Title
Serum cortisol
Description
Blood draw will be analyzed for concentration of serum cortisol using an enzyme-linked immunosorbent assay
Time Frame
4-6 weeks postpartum
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
19 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
18 to 26 weeks pregnant
have access to internet and an electronic device (phone, tablet, or computer)
willing to consume eggs
Exclusion Criteria:
score 11 or higher on the Edinburgh Postnatal Depression Scale
under 19 years of age
non-English speaking
pregnant with multiples
consume a vegan diet
self-reported use of alcohol or drugs during pregnancy
have diagnosed egg allergy
have physical, cognitive, or logistical limitations to being able to follow the study protocol
do not plan to breastfeed
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Annie J Roe, PhD
Phone
208-885-1709
Email
aroe@uidaho.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Annie J Roe, PhD
Organizational Affiliation
University of Idaho
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Idaho
City
Moscow
State/Province
Idaho
ZIP/Postal Code
83844-3183
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Annie J Roe, PhD
Phone
208-885-1709
Email
aroe@uidaho.edu
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Feasibility of Egg-Based Diet Interventions and Assessing Perinatal Mental Health
We'll reach out to this number within 24 hrs